Satsuma Pharmaceuticals I... (STSA)

NASDAQ: STSA · Real-Time Price · USD

1.10

0.00 (0.00%)

At close: Jun 07, 2023, 8:00 PM

Satsuma Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Net Income	-70.06M	-51.17M	-47.56M	-28.18M	-7.35M	-5.17M
Depreciation & Amortization	683K	393K	239K	141K	57K	10K
Stock-Based Compensation	5.71M	5.36M	4.02M	747K	170K	66K
Other Working Capital	-99K	2.31M	2.42M	-6.34M	472K	158K
Other Non-Cash Items	11.78M	48K	102K	132K	-157K	254K
Deferred Income Tax	n/a	1.27M	83K	-124K	n/a	n/a
Change in Working Capital	367K	1.1M	794K	-2.36M	295K	521K
Operating Cash Flow	-51.52M	-43M	-42.33M	-29.64M	-6.98M	-4.32M
Capital Expenditures	-472K	-2.03M	-5.17M	-551K	-402K	-58K
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	-47.77M	-88.62M	-34.01M	-99.86M	n/a	n/a
Sales Maturities Of Investments	91.61M	39.87M	97.17M	4.53M	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	43.37M	-50.78M	58M	-95.88M	-402K	-58K
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	8.74M	73.28M	-2.1M	143.06M	10.93M	n/a
Financial Cash Flow	8.74M	73.28M	-2.1M	143.06M	10.93M	n/a
Net Cash Flow	594K	-20.49M	13.57M	17.55M	3.55M	-4.38M
Free Cash Flow	-51.99M	-45.03M	-47.49M	-30.19M	-7.38M	-4.38M